European Urology Oncology

Slides:

Advertisements

Similar presentations

Volume 72, Issue 3, Pages (September 2017)

Advertisements

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer Marco Bandini, Giorgio Gandaglia, Nicola Fossati, Francesco.

Volume 68, Issue 6, Pages (December 2015)

Erectile Function Recovery After Nerve-Sparing Radical Prostatectomy for Prostate Cancer: Is Back to Baseline Status Enough for Patient Satisfaction?

Volume 62, Issue 3, Pages (September 2012)

Volume 155, Issue 3, Pages (March 1996)

The PSA Era is not Over for Prostate Cancer

Oncological outcomes of high risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy.

Oncol Res Treat 2016;39: DOI: /

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis K.

Volume 58, Issue 4, Pages (October 2010)

Testosterone Therapy in Men With Prostate Cancer

Volume 58, Issue 5, Pages (November 2010)

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer Francesco Cantiello, Giorgio.

European Urology Oncology

Volume 59, Issue 5, Pages (May 2011)

Volume 68, Issue 3, Pages (September 2015)

Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database

Volume 69, Issue 1, Pages (January 2016)

Volume 73, Issue 3, Pages (March 2018)

European Urology Oncology

Volume 70, Issue 2, Pages (August 2016)

Volume 52, Issue 4, Pages (October 2007)

Volume 63, Issue 6, Pages (June 2013)

European Urology Oncology

European Urology Oncology

Volume 68, Issue 5, Pages (November 2015)

Volume 67, Issue 2, Pages (February 2015)

Volume 53, Issue 4, Pages (April 2008)

Volume 74, Issue 2, Pages (August 2018)

Volume 67, Issue 3, Pages (March 2015)

European Urology Oncology

European Urology Oncology

Volume 61, Issue 3, Pages (March 2012)

Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients Timo F.W. Soeterik,

The PSA Era is not Over for Prostate Cancer

Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,

Volume 64, Issue 4, Pages (October 2013)

Volume 70, Issue 6, Pages (December 2016)

Volume 53, Issue 6, Pages (June 2008)

Volume 70, Issue 2, Pages (August 2016)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Prostate Cancer Nomograms: An Update

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA Nawar Hanna, Quoc-Dien Trinh,

Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy Matthew Mossanen, Kenneth.

European Urology Oncology

Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of.

European Urology Oncology

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer Felix Preisser, Michele Marchioni, Sebastiano.

European Urology Oncology

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

European Urology Oncology

Volume 50, Issue 5, Pages (November 2006)

Axel Heidenreich European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

European Urology Oncology

Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection.

Fernando P. Secin, Fernando J. Bianco, Nicholas T

European Urology Oncology

Oncoforum Urology: Prostate Cancer 2008 at a Glance

European Urology Oncology

Axel Heidenreich European Urology Supplements

European Urology Oncology

Salvage Local Treatments After Focal Therapy for Prostate Cancer

European Urology Oncology

Kaplan-Meier curves for PFS (panel A) and OS (panel B) of patients with mTCC receiving an anti-EGFR based therapy. mTCC, metastatic transverse colon cancer;

European Urology Oncology

European Urology Oncology

Presentation transcript:

European Urology Oncology Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer Alberto Martini, Giorgio Gandaglia, Nicola Fossati, Simone Scuderi, Carlo Andrea Bravi, Elio Mazzone, Armando Stabile, Simone Scarcella, Daniele Robesti, Francesco Barletta, Vito Cucchiara, Vincenzo Mirone, Francesco Montorsi, Alberto Briganti European Urology Oncology DOI: 10.1016/j.euo.2019.03.006 Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 1 Kaplan-Meier curve depicting biochemical recurrence-free survival and clinical recurrence-free survival in the overall patient population. BCR=biochemical recurrence; CR=clinical recurrence. European Urology Oncology DOI: (10.1016/j.euo.2019.03.006) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 2 Kaplan-Meier curve depicting biochemical recurrence-free survival, stratified according to margins features. BCR=biochemical recurrence; PSM=positive surgical margin. European Urology Oncology DOI: (10.1016/j.euo.2019.03.006) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 3 Kaplan-Meier curve depicting clinical recurrence-free survival, stratified according to margins features. CR=clinical recurrence; PSM=positive surgical margin. European Urology Oncology DOI: (10.1016/j.euo.2019.03.006) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 4 Kaplan-Meier curve depicting biochemical recurrence-free survival, stratified according to margins features in patients with adverse pathologic features. BCR=biochemical recurrence; PSM=positive surgical margin. European Urology Oncology DOI: (10.1016/j.euo.2019.03.006) Copyright © 2019 European Association of Urology Terms and Conditions

Fig. 5 Kaplan-Meier curve depicting clinical recurrence-free survival, stratified according to margins features in patients with adverse pathologic features. CR=clinical recurrence; PSM=positive surgical margin. European Urology Oncology DOI: (10.1016/j.euo.2019.03.006) Copyright © 2019 European Association of Urology Terms and Conditions